Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate
Sponsor: Boston Medical Center
Summary
In this study, participants will have standard Androgen Deprivation Therapy and undergo standard external beam radiation therapy to the prostate and at-risk lymph nodes by Intensity Modulated Radiation Therapy. The subsequent \*boost\* radiation therapy to the prostate alone will be given using the CyberKnife, rather than using the standard Intensity Modulated Radiation Therapy. This study will also see how CyberKnife affects the quality of the participant's life.
Official title: Phase II Study of Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate for Treatment of Localized, Non-Metastatic, High Risk Prostate Cancer
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
35
Start Date
2011-06
Completion Date
2027-12
Last Updated
2025-06-26
Healthy Volunteers
No
Conditions
Interventions
CyberKnife Boost
21 Gy in 7 Gy per day, 3 fractions, Every other day
Locations (1)
Boston Medical Center
Boston, Massachusetts, United States